Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2023-09-26 00:00:00 ET · period of report 2023-09-25 · accession 0001453687-23-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-26 | 2023-09-25 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.06 | -2,932 | 783.1K | -0.4% | -$3,108 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-25 | S | D | 2,932 | $1.06 | 783,081 | D | — | — |